|
|
| (54 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT[[Anaplastic large cell lymphoma]] |
| {{SI}}
| |
| {{DiseaseDisorder infobox |
| |
| Name = auses
| |
| | |
| Anaplastic large cell lymphoma, ALK positive | |
| | |
| ls|
| |
| ICD10 = {{ICD10|C|84|4|c|81}} |
| |
| OMIM = |
| |
| MedlinePlus = |
| |
| eMedicineSubj = |
| |
| eMedicineTopic = |
| |
| }}
| |
| {{CMG}}; {{AE}} {{AP}}
| |
| | |
| {{SK}}
| |
| | |
| ==Overview==
| |
| The Anaplastic large cell lymphoma ALK-positive ('''A'''naplastic '''L'''lymphoma '''K'''inase) consist of T-cells with abundant cytoplasm and a pleomorphic nucleus (horseshoe-shaped nucleus). This ALK-positive lymphoma has a translocation in the ALK gene, which will in turn, express the ALK protein<ref name=Swerdlow>{{cite book | last = Swerdlow | first = Steven | title = WHO classification of tumours of haematopoietic and lymphoid tissues | publisher = International Agency for Research on Cancer | location = Lyon, France | year = 2008 | isbn = 9789283224310 }}</ref>.
| |
| | |
| ==Historical Perspective==
| |
| | |
| ==Classification==
| |
| | |
| ==Pathophysiology ==
| |
| | |
| ==Causes==
| |
| | |
| == Differential Diagnosis ==
| |
| | |
| == Epidemiology and Demographics==
| |
| | |
| == Risk Factors==
| |
| | |
| == Natural History, Complications and Prognosis==
| |
| | |
| == Diagnosis ==
| |
| | |
| ===History and Symptoms===
| |
| | |
| == Treatment ==
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |